Who invested in PostEra

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Y Combinator: W20

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2022, from 1 source

Latest round: VentureMay 2022
Investors: 5

See who backed them

The rounds

May 2022
VentureAmount undisclosed
Source recordedSEC filing: $26M sold, first sale Dec 2021

Founders and team

From PostEra's own website and the SEC filings it signed: 15 on the team.

Aaron MorrisCEO
Ricardo AzzizActing Chief Medical Officer
Matthew RobinsonCTO
Tony SchroederHead of Machine Learning
Andrew DirksenSenior Software Engineer
Chris BoccioFinance Lead
Courtney TiffanyLead Investigator, Clinical Development/Operations
Jake BattleLead, Engineering
James GayvertLead, Engineering
Luke RamusTechnical Lead, Engineering
Nikki SimpsonLead Investigator, in vivo Pharmacology
Rachael SpringerPeople Operations Lead
Sergiy GamanyukLead, Engineering
Thomas PavariniTechnical Lead, Engineering
Alpha LeeExecutive Officer, Directori

Everyone who backed them

Y CombinatorAccelerator1round

Pioneer FundPrivate equity1round

HOF CapitalVC firm1round

Breyer CapitalPrivate equity1round

MetaplanetVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists PostEra as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.